Cambridge Investment Research Advisors’s GeneDx Holdings WGS Stock Holding History

Cambridge Investment Research Advisors’s Portfolio WGS Stock Details WGS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$259K	Buy	+3,767	New	+$214K	﹤0.01%	3581

Other funds holding WGS

Corvex Management New York $3.27B AUM 38.53% 1-Year Est. Return

Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

Cambridge Investment Research Advisors's WGS Position: Q2 2026 in Review

Cambridge Investment Research Advisors opened a new position in GeneDx Holdings (WGS) in Q2 2026: 3,767 shares worth $259K. The stake represents ﹤0.01% of the portfolio and ranks #3581 among its holdings.

223 funds tracked by Wall St. Rank hold WGS as of Q2 2026.

Cambridge Investment Research Advisors held 3,767 shares of GeneDx Holdings worth $259K as of Q2 2026.
GeneDx Holdings was a new Cambridge Investment Research Advisors position in Q2 2026.
GeneDx Holdings made up ﹤0.01% of Cambridge Investment Research Advisors's portfolio in Q2 2026, its #3581 holding.
223 funds tracked by Wall St. Rank held GeneDx Holdings as of Q2 2026.

Based on Cambridge Investment Research Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.